TITLE

DOW AGROSCIENCES/UNIV. OF GUELPH DEVELOPING CATTLE VACCINE

PUB. DATE
February 2004
SOURCE
Worldwide Biotech;Feb2004, Vol. 16 Issue 2, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on an research agreement signed by Dow AgroSciences Canada Inc. with the University of Guelph, which is conducting research on a vaccine to prevent a flu-like disease in cattle.
ACCESSION #
12067823

 

Related Articles

  • Step forward for plants. O'Driscoll, Cath // ICIS Chemical Business;2/13/2006, Vol. 1 Issue 6, p41 

    The article reports on a regulatory approval for a plant-made vaccine received by Dow AgroSciences from the U.S. Department of Agriculture Center for Veterinary Biologics. Its Concert Plant Cell-Produced System will be using plant cells instead of whole ones in developing vaccines. It does not...

  • Dow AgroSciences Receives Regulatory Approval for Plant-Made Vaccine. Van Arnum, Patricia // Pharmaceutical Technology;Mar2006, Vol. 30 Issue 3, p20 

    The article reports on the United States Department of Agriculture Center for Veterinary Biologics' approval for Dow AgroSciences LLC's plant-cell-culture-derived vaccine. It details the production of the vaccine from the "Dow-Agro-Sciences Concert Plant-Cell-Produced System". The system uses...

  • Dow Receives Regulatory Approval for First Plant-Made Animal Vaccine.  // BioPharm International;Mar2006, Vol. 19 Issue 3, p18 

    The article focuses on regulatory approval received by Dow AgroSciences LLC from the United States Department of Agriculture Center for Veterinary Biologics for a plant-made vaccine. The vaccine uses plant cells rather than whole plants in biologically contained environment to produce vaccines....

  • Dow, USDA lab to develop West Nile virus vaccine.  // Pest Control;Jul2004, Vol. 72 Issue 7, p10 

    Reports on the cooperative agreement signed by Dow AgroSciences LLC with the U.S. Department of Agriculture-Agricultural Research Service (USDA-ARS) laboratory, to develop a plant-made vaccine for protection against West Nile virus in Laramie, Wyoming. Research on the fatality of the virus;...

  • Dow AgroSciences seeks better vaccine. Murphy, Tom // Indianapolis Business Journal;7/17/2006, Vol. 27 Issue 19, p21 

    The article reports on the efforts of Dow AgroSciences LLC of Indianapolis, Indiana to develop plant-based vaccines. The company has received the world's first approval for a plant-made vaccine from the U.S. Department of Agriculture Center for Veterinary Biologics. According to Butch Mercer, if...

  • Plant-based vaccine system OK'd by USDA.  // DVM: The Newsmagazine of Veterinary Medicine;Mar2006, Vol. 37 Issue 3, p20 

    The article reports on the approval of Dow AgroSciences LLC's technology for vaccine production from plants by the U.S. Department of Agriculture in Indianapolis, Indiana. One of the advantages of the technology is that no components of animal origin are used, eliminating contamination concerns...

  • Module advises on best use of Fazor.  // Horticulture Week;7/29/2011, p30 

    The article reports on the recommendation of Dow AgroSciences LLC to utilize its electronic learning module for potato sprout suppression product Fazor in Great Britain.

  • DowElanco changes name.  // Chemical Market Reporter;01/12/98, Vol. 253 Issue 2, p7 

    Details the renaming of DowElanco to Dow AgroSciences effective January 1, 1998.

  • News In Brief.  // Nature Biotechnology;Mar2006, Vol. 24 Issue 3, p233 

    The article offers world news briefs. Food stores in South Africa are selling genetically modified maize and soy products. The U.S. Department of Agriculture has approved the first plant-based vaccine developed by Dow AgroSciences LLC. The U.S. Food and Drug Administration has approved the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics